PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance for Industry – FDA

Опубликовано 3 октября, 201817 декабря, 2018 frozencat

Обновление руководства FDA:

Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance for Industry

Руководство замещает Adaptive Design Clinical Trials for Drugs and Biologics – 2010.

Рубрики: Блог

Навигация по записям

Предыдущая запись: Определение объема выборки для исследований биоэквивалентности с использованием компьютерного моделирования
Следующая запись: Работа с данными в IBM SPSS: присвоение меток переменным из другого источника

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20170731 215207
20170803 172013
20180131 184204
IMG-20170806-WA0050
IMG-20170807-WA0022
IMG-20170802-WA0014
  • Testing Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) Donors for Relevant Communicable Disease Agents and Diseases
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-13 By FDA
  • Pharmacy Compounding Advisory Committee Roster
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Office of New Drugs Custom Medical Queries (OCMQs)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Standard Safety Tables and Figures (ST&Fs)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • CDER Manual of Policies & Procedures | MAPP
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Nonprescription Drugs Advisory Committee Roster
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • eSubmitter Application History
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-13 By FDA
  • What’s New for Biologics
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-13 By FDA
  • Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-13 By FDA
  • Novel Drug Approvals for 2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Drug Trials Snapshots
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-13
  • UPDATED: Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer & Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Due to Presence of Methanol
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-13 By FDA
  • Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-13
  • Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-13
Предыдущие записи
Тема: Scaffold от Danny Cooper.